Unknown

Dataset Information

0

Structural basis for therapeutic inhibition of influenza A polymerase PB2 subunit.


ABSTRACT: Influenza virus uses a unique mechanism to initiate viral transcription named cap-snatching. The PB2 subunit of the viral heterotrimeric RNA polymerase binds the cap structure of cellular pre-mRNA to promote its cleavage by the PA subunit. The resulting 11-13 capped oligomer is used by the PB1 polymerase subunit to initiate transcription of viral proteins. VX-787 is an inhibitor of the influenza A virus pre-mRNA cap-binding protein PB2. This clinical stage compound was shown to bind the minimal cap-binding domain of PB2 to inhibit the cap-snatching machinery. However, the binding of this molecule in the context of an extended form of the PB2 subunit has remained elusive. Here we generated a collection of PB2 truncations to identify a PB2 protein representative of its structure in the viral heterotrimeric protein. We present the crystal structure of VX-787 bound to a PB2 construct that recapitulates VX-787's biological antiviral activity in vitro. This co-structure reveals more extensive interactions than previously identified and provides insight into the observed resistance profile, affinity, binding kinetics, and conformational rearrangements induced by VX-787.

SUBMITTER: Ma X 

PROVIDER: S-EPMC5571044 | BioStudies | 2017-01-01

REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC4325764 | BioStudies
2014-01-01 | S-EPMC3893164 | BioStudies
2018-01-01 | S-EPMC5778463 | BioStudies
2017-01-01 | S-EPMC5355620 | BioStudies
2016-01-01 | S-EPMC4697171 | BioStudies
2012-01-01 | S-EPMC3410856 | BioStudies
2017-01-01 | S-EPMC5444859 | BioStudies
2020-01-01 | S-EPMC7040080 | BioStudies
2016-01-01 | S-EPMC5108440 | BioStudies
2009-01-01 | S-EPMC2699363 | BioStudies